Track the BioSyent Inc. stock price and the full management transaction log of the company, a listed issuer based in Canada. Shares trade on the CA market, under the authority of SEDI. Operating in the Health Care sector, BioSyent Inc. has published 77 reports. Market capitalisation: €180.4m. The latest transaction was reported on 28 August 2026 (10 - Acquisition or disposition in the public market). Among the most active insiders: BioSyent Inc.. Every trade is openly available.
77
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioSyent Inc. Strong Buy (bullish), based on 1 analysts. Average price target: CA$18.00.
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,122 of 29,062 companies
73.1
score / 100
Value
57
Quality
89
FCF yld4.8%
Earn yld5.1%
EV/EBITDA13.8x
ROE24%
Gross mgn77%
Net mgn21%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.